Trupanion, Inc. (TRUP) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Trupanion, Inc. provides medical insurance for cats and dogs in the United States, Canada, and select European countries. The company operates two segments: a core Subscription Business (direct-to-consumer) and an Other Business segment (underwriting for third parties, primarily Pets Best). As of July 31, 2025, there were approximately 42.99 million shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenue | $353.6 million | $314.8 million | $695.5 million | $620.9 million |
| Net Income (Loss) | $9.4 million | ($5.9 million) | $7.9 million | ($12.7 million) |
| Diluted EPS | $0.22 | ($0.14) | $0.18 | ($0.30) |
| Operating Income (Loss) | $2.3 million | ($5.5 million) | $0.8 million | ($11.6 million) |
| Operating Cash Flow (YTD) | $31.0 million (2025) vs $9.3 million (2024) | |||
| Cash & Short-Term Investments | $319.6 million (as of June 30, 2025) | |||
| Long-Term Debt | $113.1 million (as of June 30, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 12% year-over-year (Q2) and 12% year-over-year (YTD). Subscription business revenue grew 16%, driven by an 11% increase in monthly average revenue per pet ($79.93 vs $71.72) and increased pet months.
- Profitability Turnaround: The company returned to profitability, reporting net income of $9.4 million in Q2 2025 compared to a net loss of $5.9 million in Q2 2024. This was significantly aided by a one-time gain.
- Unusual Item (Nonmonetary Exchange): A major driver of Q2 income was a $7.8 million realized gain from exchanging preferred stock in Baystride, Inc. for intellectual property. This gain is recorded in "Other (income), net."
- Expense Increases: General and administrative expenses rose 32% QoQ and 34% YTD, driven by compensation and Canadian underwriting fees. New pet acquisition costs increased 11% QoQ as the company deployed more capital to acquire members.
- Debt Reduction: In June 2025, the company made a $14.9 million principal repayment on its Initial Term Loan.
Guidance, Outlook, and Risks
- Outlook: Management expects the "Other Business" segment to continue slowing due to the run-off of Pets Best policies. The company intends to assume full insurance risk for European products in the future rather than acting as a broker.
- Acquisition Strategy: The company is increasing marketing spend to acquire new pets in a "disciplined manner," resulting in a higher Average Pet Acquisition Cost (PAC) of $276 in Q2 2025 compared to $231 in Q2 2024.
- Liquidity: The company holds $319.6 million in cash and short-term investments. Management believes operating cash flow is sufficient to fund operations for the next 12 months.
- Risks:
- Regulatory Capital: Insurance subsidiaries must maintain specific risk-based capital levels, limiting the ability to distribute cash to the parent company without approval.
- Contract Termination: The "Other Business" segment relies on third-party contracts (e.g., Pets Best) which are non-exclusive and subject to termination, potentially causing revenue loss.
- Pricing Lag: Timing mismatches between veterinary inflation and pricing adjustments can impact margins.
Investor Verification Checklist
- Quality of Earnings: Verify the sustainability of profitability by excluding the $7.8 million one-time gain from the Baystride transaction.
- Subscription Growth: Confirm the trend of increasing Monthly Average Revenue Per Pet (MARPP) and whether it offsets the rising Pet Acquisition Cost (PAC).
- Claims Development: Review the "Reserve for Veterinary Invoices" note for unfavorable development ($2.1 million YTD in Subscription) which indicates higher-than-expected claims frequency or severity.
- Debt Covenants: Confirm continued compliance with the Credit Facility covenants, especially given the recent principal repayment.
- Segment Mix: Monitor the run-off rate of the "Other Business" segment and the transition of European markets from commission-based to underwritten risk.